By Andrew Karpan ( April 8, 2021, 6:54 PM EDT) -- An Indian drugmaker wants the full Federal Circuit to take another look at a ruling that dashed its efforts to break Amgen's grip on its anti-cancer drug Kyprolis, arguing that a specification attached to a later patent on the drug was "trivial."...
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.